IRVING, Texas — Revision Skincare has officially appointed Lisa Paley as its new CEO, marking a significant leadership transition for the company. Paley brings nearly 30 years of executive experience across major consumer healthcare brands including Haleon, GSK, Pfizer, and Johnson & Johnson. She is recognized as a transformational leader with a strong track record in driving growth and innovation.
“Lisa’s extensive experience building science-backed brands across the consumer health, wellness and beauty spectrum makes her the ideal leader to accelerate our business in the U.S. and key global markets,” said Matt Farron, Partner, Co-Head of Consumer Group at Gryphon Investors. “She has a stellar reputation as a visionary leader who can deliver sustained growth, scale innovation across geographies and build high-performance cultures with an engaging, people-driven leadership style. We’re thrilled to welcome Lisa to lead Revision Skincare’s next stage of growth.”
As professional and consumer health and beauty trends continue to intersect, Paley will leverage her expertise building powerhouse consumer brands in the US and globally to reinvigorate Revision Skincare’s business and unlock its full potential. She joins the company from Haleon, the largest global consumer health company, where she served as President of North America and was a founding member of the Executive Leadership Team. During her tenure, she led the company’s North American business through its landmark corporate spin-off from GSK and its public listings on both the NYSE and FTSE.
“I’m honored to join Revision Skincare as CEO at such an exciting time in the beauty industry, when we’re seeing consumer health and beauty trends converge in new ways,” said Paley. “Our brand has a powerful foundation of scientific innovation and proven results, and I look forward to building on that legacy to bring even more transformative skin health solutions to professionals and consumers. At Revision, we believe beauty and confidence come from skin that’s nurtured for the long term, and my goal is to extend our impact while staying true to our mission of delivering trusted, physician-dispensed skincare.”
At Haleon, and at GSK Consumer Healthcare (a joint venture with Pfizer) previously, Paley delivered category-leading performance across iconic brands while pioneering advancements in AI-driven marketing, e-commerce, strategic revenue management, and organizational culture and engagement. Prior to GSK, she held progressively senior roles at Pfizer Consumer Healthcare, ultimately serving as President, North America, with P&L responsibility over the US, Canada and the Caribbean. Paley also previously served as VP of US Sales at Johnson & Johnson. A former Certified Public Accountant, she began her career at Deloitte. Paley holds a BS in Accounting from Miami University and an Executive MBA from The Ohio State University.
Over her career, Paley has led several boards and committees for prominent industry associations. She previously served as Chairman of the Board of the Consumer Healthcare Products Association (CHPA) and led the National Association of Chain Drug Stores (NACDS) Retail Advisory Board. She has also served as a board member of NextUp, Excel Share Group and WE, an organization dedicated to expanding women’s voices in the consumer health and wellness space.
